Medical Device Network on MSN
Sacral neuromodulation: broadening Boston Scientific’s European urology portfolio
Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results